BLINATUMOMAB IMPROVED OVERALL SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY (TOWER)
(Abstract release date: 05/19/16)
EHA Library. Topp M. 06/10/16; 135182; S149
Topic: 3Aa B lymphoblastic leukemia/lymphomaDisclosure(s): Universitätsklinikum Würzburg
To be announced!
This module will be available soon.
This module will be available soon.